Baicalein inhibited the migration of MDA-MB-231 breast cancer cells by suppressing SATB1, a nuclear matrix binding protein, and the Wnt/β-catenin pathway in a dose-dependent manner [32]. This evidence concerns the gene SATB1 and breast carcinoma.